Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Roma
Clinical trial register · Italy

Clinical Trials in Roma, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 17 Bologna 12 Roma 9 Padova 5 Novara 5
Narrow the registerReset
Recruitment status
Phase
Site location
Milan17 Bologna12 Roma9 Padova5 Novara5
All 31 locations
Target enrolment
to

Trials with a site in Roma

9 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
BeOne Medicines
Phase 1
86
Milan, Naples, Roma, Rozzano
2025-12-11
Recruiting
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
NCT06427941Metastatic Hepatocellular Carcinoma, Local Advanced Hepatocellular Carcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Extragonadal Yolk Sac Tumors
BeOne Medicines
Phase 1/2
630
Naples, Padova, Roma, Rozzano
2024-07-23
Active, closed
A Study to Investigate Efficacy and Safety of BCL2 Inhibitor Sonrotoclax as Monotherapy and in Combination With Zanubrutinib in Adults With Waldenström Macroglobulinemia
NCT05952037Waldenstrom Macroglobulinemia, Waldenstrom's Macroglobulinemia Recurrent, Waldenstrom's Macroglobulinemia Refractory
BeOne Medicines
Phase 2
114
Bologna, Brescia, Milan, Pavia, Roma, Udine
2023-10-23
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
BeOne Medicines
Phase 1/2
689
Bologna, Milan, Roma, Verona
2021-09-13
Active, closed
BeOne Medicines
Phase 1
437
Milan, Perugia, Ravenna, Roma, Verona
2020-03-24
Active, closed
BeOne Medicines
Phase 3
955
Bologna, Meldola, Milan, Modena, Novara, Ravenna, Roma, Terni
2020-01-16
Rows per page Showing 1–9 of 9
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/roma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 9 of those studies with a site in Roma that also match the filters currently applied.

How many clinical trials are recruiting in Roma?

6 of the 9 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Roma), 9 studies
PhaseStudiesRecruitingShare
Phase 34344.4%
Phase 12122.2%
Phase 1/22222.2%
Phase 21011.1%

Most active sponsors

Lead sponsors with the most studies (Roma)
Lead sponsorStudiesRecruiting
BeOne Medicines96
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.